Pfizer, Moderna and Gilead reputations climb on COVID-19 vaccine and treatment news, according to Harris Poll

Pfizer, Moderna and Gilead reputations climb on COVID-19 vaccine and treatment news, according to Harris Poll

Source: 
Fierce Pharma
snippet: 

When it comes to COVID-19 vaccines and treatments, more news is good news. That’s the latest takeaway from consumer sentiment tracking by The Harris Poll. Pharma companies now in the news reaped hefty reputation boosts, according to early August data.

Pfizer, Gilead and Moderna specifically are trending positively with consumers who'd seen the news about their respective treatments and vaccines, the poll taken July 30-Aug. 3 found.